IP Library Granted Patent US 7,368,250
Granted Patent B2
US 7,368,250 · App. 10/916,250 · Granted May 6, 2008

Compositions and methods for the diagnosis and treatment of tumor

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,368,250
App. No.
10/916,250
Granted
May 6, 2008
Kind
B2
Abstract

The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumor in mammals and to methods of using those compositions of matter for the same.

Claims (10)

1. A method of cancer diagnosis, comprising determining the expression level of a protein consisting of:

(a) the amino acid sequence shown as SEQ ID NO:3; or

(b) an amino acid sequence encoded by the full-length coding region of the nucleotide sequence shown as SEQ ID NO: 1, in a tissue sample suspected of containing tumor cells obtained from a human patient, and in a normal tissue sample of the same cell type by contacting said tissue samples with an antibody that binds to said protein and allowing the binding of said antibody to said protein to occur, wherein the patient is diagnosed with cancer, if said protein is overexpressed in the tissue sample suspected of containing tumor cells relative to the normal tissue sample.

2. The method of claim 1 , wherein said antibody is a monoclonal antibody.

3. The method of claim 1 , wherein said antibody is an antibody fragment, and said antibody fragment binds to the protein of SEQ ID NO: 3.

4. The method of claim 1 , wherein said antibody is a chimeric or a humanized antibody.

5. The method of claim 1 , wherein said antibody is produced in bacteria.

6. The method of claim 1 , wherein said antibody is produced in CHO cells.

7. The method of claim 1 , wherein said cancer is ovarian cancer, breast cancer or uterine cancer.

8. The method of claim 1 , wherein said antibody is labeled.